“Cellular mechanisms of neurogenic inflammation”, Richard J, Vasko M.  Pharmacol. & Experimental Therapeutics 2002; Vol. 302, #3: pp: 839-845.

“Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases”, Wang H, et al.  Neuroscience 2002; Vol. 114, #3: pp: 529-546.

“Deep tissue inflammation up-regulates neuropeptides and evokes nociceptive behaviors, which are modulated by a neuropeptide antagonist”, Ambalavanar R, et al. Pain 2006; Vol. 120: pp: 53-68.

“Presence and distribution of sensory nerve fibers in human peritoneal adhesions”, Sulaiman H, et al. Ann. Of Surg. 2001; Vol. 234(2): pp: 256-261.

“Inflammation with no exonal damage of the rat saphenous nerve trunk induces ectopic discharge and mechanosensitivity in myelinated exons”, Eliav E, Benoliel R, Tal M.  Neuroscience Letters 2001; Vol. 311, #1: pp: 49-52.

The important role of neuropeptides in complex regional pain syndrome”, Birklein, F, et al.  Neurology 2001; Vol. 57: pp: 2179-2184.

“The association between ACE inhibitors and complex regional pain syndrome:  Suggestions for a neuro-inflammatory pathogenesis of CRPS”, Pain 2009; Vol. 142: pp: 218-224.

“Post-traumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems”, Aller M, et al.  Experimental Biol. in Med. 2004; Vol. 229: pp: 170-181.

“Migraine as an inflammatory disorder”, Waeber C, Moskowitz M.  Neurol. Vol. 64 (supplement 2) to May/2005: pp: S9-S15.

“Neurogenic mechanisms in bronchial inflammatory disease”, Groneberg D.  Allergy; Vol. 59, #11: pp: 1139-1152.

“Neurogenic inflammation and sensitivity to environmental chemicals”, Meggs W.  Environ. Health Perspect. 1993; Vol. 101(3): pp: 234-238.

“Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats”, Nimmo A.  Neuropeptides 2004; Vol. 38: pp: 40-47.